Melbourne, Australia

Adam Cusick

This inventor holds 1 USPTO granted patent. Top assignee: Invetech, Inc.. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adam Cusick - Innovator in Centrifugation Technology

Introduction

Adam Cusick is a notable inventor based in Melbourne, Australia. He has made significant contributions to the field of centrifugation technology, particularly with his innovative apparatus designed for counter flow centrifugation. His work has implications for various scientific and industrial applications.

Latest Patents

Adam Cusick holds a patent for an "Apparatus for performing counter flow centrifugation and method of using same." This invention includes a vessel, a gear fixedly attached to the vessel, a handle assembly, and a plurality of tubes extending through the handle assembly to the vessel. The design allows the vessel to rotate at twice the speed of the handle assembly when inserted into a bowl of the counter flow centrifuge. This innovation enhances the efficiency and effectiveness of centrifugation processes.

Career Highlights

Adam is currently employed at Invetech, Inc., where he continues to develop and refine technologies that advance the field of centrifugation. His expertise and innovative mindset have positioned him as a valuable asset in his organization.

Collaborations

Throughout his career, Adam has collaborated with talented individuals such as Ian Fitzpatrick and Mark Rob. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Adam Cusick's contributions to centrifugation technology exemplify the spirit of innovation. His patent and ongoing work at Invetech, Inc. highlight his commitment to advancing scientific methods and improving industrial processes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…